Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis

The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of abatacept for cGvHD therapy in a retrospective study with 15 patients who...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Hematol
Main Authors: Wertheimer, Tobias, Dohse, Marius, Afram, Gabriel, Weber, Daniela, Heidenreich, Martin, Holler, Barbara, Kattner, Anna-Sophia, Neubauer, Andreas, Mielke, Stephan, Ljungman, Per, Holler, Ernst, Herr, Wolfgang, Edinger, Matthias, Martínez, Antonio Pérez, Fante, Matthias, Wolff, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914235/
https://ncbi.nlm.nih.gov/pubmed/33515310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-021-04434-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados